Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.34 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.34 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.34 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4962159 | 0.81 | ALDH1A1 (0.39) | ALDH1A1MEN1KMT2ACA2CA1 | |
| SCHEMBL13096335 | 0.75 | PKM (0.45) | ALDH1A1MEN1KMT2ACA2CA1 | |
| SCHEMBL64494 | 0.75 | CA2 (0.43) | ALDH1A1MEN1KMT2ACA2CA1 | |
| SCHEMBL5971582 | 0.74 | ALDH1A1 (0.33) | ALDH1A1KMT2APOLBPTGS1PTGS2 | |
| SCHEMBL12049908 | 0.74 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2ACA2CA1 | |
| SCHEMBL29279172 | 0.73 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2ACA2CA1 | |
| SCHEMBL14331424 | 0.72 | HSP90AA1 (0.48) | ALDH1A1MEN1KMT2ACA2CA1 | |
| SCHEMBL9888504 | 0.72 | NR1H3 (0.49) | ALDH1A1MEN1KMT2ACA2CA9 | |
| SCHEMBL176126 | 0.72 | NR1H3 (0.45) | ALDH1A1MEN1KMT2ACA2CA1 | |
| SCHEMBL15082546 | 0.72 | ALDH1A1 (0.37) | ALDH1A1MEN1KMT2ACA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050074668-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2005-04-07 | — | — | US | disclosed |
| US-20030052310-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2003-03-20 | — | — | US | disclosed |
| EP-0850920-B1 | Ionic conductive materials comprising salts of perfluorinated amides and uses thereof | CENTRE NAT RECH SCIENT (FR) | 2002-09-11 | — | — | EP | disclosed |
| US-20020009650-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2002-01-24 | — | — | US | disclosed |
| US-6319428-B1 | Perfluorinated amide salts and their uses as ionic conducting materials | HYDRO-QUEBEC (CA) | 2001-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020009650-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | AFF4, NHERF1, AFF2 | ALDH1A1 1647/4885MEN1 2784/4885KMT2A 722/4885 |
| US-20050074668-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | AFF4, AFF2, AFF1 | ALDH1A1 1869/4885MEN1 2785/4885KMT2A 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.